Long Liao

887 total citations · 2 hit papers
13 papers, 640 citations indexed

About

Long Liao is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Long Liao has authored 13 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Epidemiology. Recurrent topics in Long Liao's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (3 papers). Long Liao is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related gene regulation (3 papers). Long Liao collaborates with scholars based in China, Hong Kong and Netherlands. Long Liao's co-authors include Bin Li, Yan He, Yuan‐Han Yang, Qing‐Yu He, Ziting Yao, Miaomiao Sun, Kuisheng Chen, Can‐Can Zheng, Qihua Zhang and Wen Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Advanced Science.

In The Last Decade

Long Liao

12 papers receiving 638 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer

2022 181 citations Ziting Yao, Yuan‐Han Yang et al. Cancer Communications profile →
Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner

2023 98 citations Long Liao, Yan He et al. Cell Research profile →

Peers

Countries citing papers authored by Long Liao

Since Specialization

Citations

This map shows the geographic impact of Long Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Liao more than expected).

Fields of papers citing papers by Long Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Liao. The network helps show where Long Liao may publish in the future.

Co-authorship network of co-authors of Long Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Long Liao. A scholar is included among the top collaborators of Long Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Liao. Long Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinoma 2025 ·Cellular Oncology ·(unknown), Yuchen Guo, Xiao Hu, Ling Jing, Haigang Geng, Qingsong Ye, Linmeng Zhang, (unknown), Long Liao, Yang Ge, Quan Zheng, (unknown)	0
2	Deciphering the role of the MALT1–RC3H1 axis in regulating GPX4 protein stability 2024 ·Proceedings of the National Academy of Sciences ·Jun Wang, Long Liao, Beiping Miao, Bo Yang, Botai Li, Xuhui Ma, (unknown), Shanshan Wu, Jia He, Qianqian Zhang, Shuyi Ji, Guang‐Zhi Jin, Jianming Zhang, Ying Cao, Hui Wang, Wenxin Qin, Chong Sun, René Bernards, Cun Wang	5
3	Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner breakdown → 2023 ·Cell Research ·Long Liao, Yan He, Shujun Li, Xiaomei Yu, Zhichao Liu, Yiyao Liang, Yang Han, Jing Yang, (unknown), (unknown), Wei Xian, (unknown), (unknown), Can‐Can Zheng, Chao Cheng, Ang Li, Zhigang Li, Jinbao Liu, Bin Li	98
4	Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis 2023 ·EBioMedicine ·Wen Xu, Long Liao, Wei Dai, Can‐Can Zheng, (unknown), (unknown), Qihua Zhang, Zhi‐Hao Huang, (unknown), Yanru Qin, Chen Kuisheng, Ming‐Liang He, Simon Law, Maria Li Lung, Qing‐Yu He, Bin Li	14
5	Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3 2022 ·Cancer Research ·Long Liao, Yan He, (unknown), (unknown), (unknown), Jing Yang, (unknown), Can‐Can Zheng, Qing‐Yu He, Yan Li, Bin Li	72
6	Blockade of Nuclear β‐Catenin Signaling via Direct Targeting of RanBP3 with NU2058 Induces Cell Senescence to Suppress Colorectal Tumorigenesis 2022 ·Advanced Science ·Can‐Can Zheng, Long Liao, Yaping Liu, Yuan‐Han Yang, Yan He, (unknown), Shujun Li, Ting Liu, Wen Xu, Bin Li	13
7	New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer breakdown → 2022 ·Cancer Communications ·Ziting Yao, Yuan‐Han Yang, Miaomiao Sun, Yan He, Long Liao, Kuisheng Chen, Bin Li	181
8	Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner 2021 ·Acta Pharmaceutica Sinica B ·Can‐Can Zheng, Xiaomei Yu, Yiyao Liang, (unknown), Yan He, Long Liao, (unknown), Yuan‐Han Yang, Xingfeng Yin, Ang Li, Qing‐Yu He, Bin Li	67
9	Targeting PP2A with lomitapide suppresses colorectal tumorigenesis through the activation of AMPK/Beclin1-mediated autophagy 2021 ·Cancer Letters ·Qian Zuo, Long Liao, Ziting Yao, Yaping Liu, (unknown), Shujun Li, Xingfeng Yin, Qing‐Yu He, Wenwen Xu	27
10	Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2‐ERK Signaling to Suppress Esophageal Cancer Metastasis 2020 ·Advanced Science ·Wen Xu, Zhi‐Hao Huang, Long Liao, Qihua Zhang, Junqi Li, Can‐Can Zheng, Yan He, (unknown), Yang Wang, (unknown), Qian Zuo, (unknown), Qingsheng Yang, Jianfu Zhao, Yanru Qin, Li‐Yan Xu, En‐Min Li, Hua‐Xin Liao, Bin Li, Qing‐Yu He	42
11	Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics 2020 ·Small Methods ·Long Liao, Ziting Yao, Wang‐Kai Fang, Qing‐Yu He, Wen Xu, Bin Li	5
12	Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission 2020 ·Theranostics ·Huifang Hu, Wen Xu, (unknown), Yan He, Wei‐Xia Zhang, Long Liao, Qihua Zhang, Lei Han, Xingfeng Yin, (unknown), Yun-long Pan, Bin Li, Qing‐Yu He	46
13	Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis 2020 ·Cell Death and Disease ·Hong Pan, Qin‐Wen Liu, Yao Xie, Qihua Zhang, Long Liao, Qing‐Yu He, Bin Li, Wen Xu	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact